VEGFA and diabetic macular edema: Anti-vascular endothelial growth factor (VEGF) drugs can reduce the expression of VEGF and inhibit intraocular neovascularization.7 In addition, these drugs can be injected into the vitreous cavity to maximize their pharmacological effects, and have become the first-line drugs for diabetic macular edema.